DROPERIDOL HIKMA 2,5 mg/mL, solution injectable
solution injectable
intraveineuse
Autorisation active
Procédure décentralisée
Commercialisée
2/9/2018
HIKMA FARMACEUTICA (PORTUGAL)
Business Listing - September 04, 2021
This is a premium business listing. Stand out from the competition!